Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Divestments (2016 - 2025)

Historic Divestments for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to $186.3 million.

  • AC Immune's Divestments rose 21220.2% to $186.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.6 million, marking a year-over-year increase of 7584.51%. This contributed to the annual value of -$113002.8 for FY2016, which is 5417.01% up from last year.
  • As of Q3 2025, AC Immune's Divestments stood at $186.3 million, which was up 21220.2% from $29.6 million recorded in Q1 2025.
  • In the past 5 years, AC Immune's Divestments ranged from a high of $186.3 million in Q3 2025 and a low of -$166.0 million during Q3 2024
  • For the 5-year period, AC Immune's Divestments averaged around -$7.0 million, with its median value being -$3.1 million (2021).
  • Its Divestments has fluctuated over the past 5 years, first soared by 801387.77% in 2023, then plummeted by 320658.59% in 2024.
  • Quarter analysis of 5 years shows AC Immune's Divestments stood at -$26.9 million in 2021, then soared by 80.26% to -$5.3 million in 2022, then skyrocketed by 200.78% to $5.3 million in 2023, then tumbled by 3206.59% to -$166.0 million in 2024, then soared by 212.2% to $186.3 million in 2025.
  • Its Divestments stands at $186.3 million for Q3 2025, versus $29.6 million for Q1 2025 and -$166.0 million for Q3 2024.